www.neurelis.comBioTechFounded: 2007Funding to Date: $247.94MM
Neurelis is a neuroscience company focusing on the development and commercialization of product candidates for epilepsy and the broader central nervous system market.
For more details on financing and valuation for Neurelis, register or login.
Already registered? Click here to log in
To read this article and more news on Neurelis, register or login.
Already registered? Click here to log in.
Forge and SharesPost have teamed up to provide you with an enhanced trading experience.